GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Embecta Corp (FRA:JX7) » Definitions » Other Long Term Assets

Embecta (FRA:JX7) Other Long Term Assets : €191 Mil (As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Embecta Other Long Term Assets?

Embecta's other long-term assets for the quarter that ended in Dec. 2024 was €191 Mil.

Embecta's quarterly other long-term assets increased from Jun. 2024 (€159 Mil) to Sep. 2024 (€189 Mil) and increased from Sep. 2024 (€189 Mil) to Dec. 2024 (€191 Mil).

Embecta's annual other long-term assets increased from Sep. 2022 (€96 Mil) to Sep. 2023 (€132 Mil) and increased from Sep. 2023 (€132 Mil) to Sep. 2024 (€189 Mil).


Embecta Other Long Term Assets Historical Data

The historical data trend for Embecta's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Embecta Other Long Term Assets Chart

Embecta Annual Data
Trend Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Other Long Term Assets
Get a 7-Day Free Trial 9.34 9.69 96.45 131.56 189.39

Embecta Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 158.37 158.52 159.23 189.39 191.00

Embecta Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.


Embecta Business Description

Traded in Other Exchanges
Address
300 Kimball Drive, Suite 300, Parsippany, NJ, USA, 07054
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Embecta Headlines

No Headlines